Immunogenic Properties
Immunogenic Properties - Related Videos
05:42
Using a Sandwich ELISA to Determine the Immunogenic Glycoprotein Content in a Vaccine
0 Views •
2025
This video showcases an indirect enzyme-linked immunosorbent assay or ELISA sandwich immunocapture assay designed to assess immunogenic glycoprotein levels in vaccines. The assay plate, containing glycoprotein-specific antibodies, is incubated with serially diluted vaccine samples, including reference and test vaccines, followed by immunoassay to quantify glycoprotein content in the test vaccine.
10:52
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
0 Views •
Cited by 10 •
2010
Autoimmune hypophysitis can be reproduced in mice by injecting an extract of mouse pituitary proteins.
12:08
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
0 Views •
Cited by 10 •
2019
The transimmunization (TI) device or plate and related protocols have been developed to replicate the key features of extracorporeal photochemotherapy (ECP), in an experimental setting, allowing for production of physiologically activated, tunable dendritic cells (DCs) for cancer immunotherapy.
02:57
Physical and Chemical Properties of Matter
0 Views •
2020
The characteristics that enable us to distinguish one substance from another are called properties. Physical Properties of Matter A physical property is a characteristic of matter that is not associated with a change in its chemical composition. Familiar examples of physical properties include density, color, hardness, melting and boiling points, and electrical conductivity. We can observe some physical properties, such as density and color, without changing the physical state of the matter...
02:58
Properties of Transition Metals
0 Views •
2020
Transition metals are defined as those elements that have partially filled d orbitals. As shown in Figure 1, the d-block elements in groups 3–12 are transition elements. The f-block elements, also called inner transition metals (the lanthanides and actinides), also meet this criterion because the d orbital is partially occupied before the f orbitals. Figure 1: Periodic Table. The transition metals are located in groups 3–11 of the periodic table. The inner transition metals are in the two rows...
FAQs
Molecular foreignness, structural complexity, and size shape how immune receptors and cells recognize a candidate substance. More foreign and structurally complex molecules may present a broader or more distinctive set of epitopes, whereas simpler structures can offer fewer recognizable targets. These variables help explain why microbial components or vaccine antigens can differ markedly in response strength.
The decisive cellular step is the processing of antigenic material by antigen-presenting cells and the display of resulting epitopes through major histocompatibility complex molecules. This presentation provides the information required for antigen-specific T-cell activation, which supports coordinated cellular immunity and helps promote B-cell responses. Differences in processing or display can therefore alter the resulting immune response.
Dose and route of exposure influence the conditions under which immune cells encounter an antigen. Their effects must be interpreted together with molecular foreignness, structure, size, and epitope presentation rather than considered in isolation. Comparing these variables helps researchers understand why the same substance may produce different levels or types of antibody, cellular, or memory responses.
Assessment combines the substance's molecular characteristics with the immune outcomes it produces. Researchers consider foreignness, complexity, size, dose, exposure route, and whether antigen-presenting cells can display relevant epitopes through MHC molecules. They then examine whether antigen-specific activity leads to antibody production, cellular immunity, and immunological memory, providing a basis for comparing candidate antigens.
Vaccine development uses immunogenic properties to identify antigens capable of generating protective immune responses. Researchers consider whether an antigen can be processed and displayed effectively, activate antigen-specific T and B cells, and produce durable immunological memory. These considerations help explain why some microbial antigens support strong protection, while others produce limited or poorly controlled immunity.
For therapeutic proteins, immunogenic properties help researchers evaluate whether the protein may stimulate an antigen-specific host response. In infection research, the same framework helps compare microbial antigens according to their ability to provoke antibody production, cellular immunity, or memory. This context connects molecular features and antigen presentation with differences in protection or immune control.